Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon

Genetic test highly sensitive to colon cancer precursors

A noninvasive test to detect cancer precursors in body fluids has been shown to be able to detect genetic variations that initiate colon cancer, potentially signaling an alternative screening method to the standard colonoscopy, according to a study published Sept. 4 in Cancer Prevention Research.

MITA Applauds AATS for Endorsement of Low-Dost CT for High-Risk Lung Cancer Patients

The Medical Imaging & Technology Alliance (MITA) today applauded the American Association for Thoracic Surgery (AATS) for endorsing the United States Preventive Services Task Force’s (USPSTF) draft recommendation for annual low-dose computed tomography scans (LDCT) for individuals at high-risk of developing lung cancer.

Ten outstanding ASTRO members named Fellows

The American Society for Radiation Oncology (ASTRO) has selected 10 distinguished members to receive the Fellow of ASTRO designation (FASTRO). The 2013 class of Fellows will receive the recognition during the Awards Ceremony on Tuesday, September 24, at ASTRO’s 55th Annual Meeting, September 22-25, 2013, at the Georgia World Congress Center in Atlanta.

Optimal contrast dose determined for spotting liver lesions

For the assessment of hypervascular hepatocellular carcinoma (HCC), the optimal iodine dose of contrast material for hepatic arterial-dominant phase (HAP) imaging has been shown to be between 567-647 mgl/kg, according to a study published in the September issue of Academic Radiology.

Limits of imaging: Kidney removal for benign masses ups costs, complications

Approximately one in six patients who had their kidneys removed due to renal cell carcinoma were later found to have a benign renal mass, underscoring the challenge diagnostic imaging faces in distinguishing between benign and malignant renal tumors, according to a study published Aug. 12 in the American Journal of Managed Care.

Thumbnail

MR-guided cryoablation safe, feasible addition to prostate cancer treatment arsenal

MR-guided focal cryoablation is feasible and safe for treating recurrent prostate cancer after radiotherapy, representing a new option to combat the disease, according to a small study published in the August issue of Radiology.

Thumbnail

MR + US-guided targeted biopsy boosts prostate cancer detection

Multiparametric MR imaging before a transrectal ultrasound (US)-guided targeted biopsy improves detection of prostate cancer over the standard extended systematic biopsy, according to a study published in the August issue of Radiology.

NEJM’s colorful explanation of how radium-223 targets bone metastases

Last month, a study published in The New England Journal of Medicine (NEJM) demonstrated how radium-223 could reduce the risk of death in patients with castration-resistant prostate cancer by targeting bone metastases, a common complication.

Displaying 673 - 680 of 2554

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.